Page last updated: 2024-10-16

2,3-butylene glycol and Chronic Disease

2,3-butylene glycol has been researched along with Chronic Disease in 1 studies

2,3-butylene glycol: RN given refers to cpd without isomeric designation
butane-2,3-diol : A butanediol in which hydroxylation is at C-2 and C-3.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishina, M1
Kato, K1
Matsushita, K1
Hayashi, M1
Matsuda, H1

Other Studies

1 other study available for 2,3-butylene glycol and Chronic Disease

ArticleYear
Proton nuclear magnetic resonance detects leucine, 2,3-butanediol, and a prominent increase in the level of choline in the sera from patients chronically infected with schistosomiasis japonica.
    Physiological chemistry and physics and medical NMR, 1997, Volume: 29, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Butylene Glycols; Child; Choline; Chronic Disease; Femal

1997